58 research outputs found

    Deep convective clouds at the tropopause

    Get PDF
    Data from the Atmospheric Infrared Sounder (AIRS) on the EOS Aqua spacecraft each day show tens of thousands of Cold Clouds (CC) in the tropical oceans with 10 μm window channel brightness temperatures colder than 225 K. These clouds represent a mix of cold anvil clouds and Deep Convective Clouds (DCC). This mix can be separated by computing the difference between two channels, a window channel and a channel with strong CO<sub>2</sub> absorption: for some cold clouds this difference is negative, i.e. the spectra for some cold clouds are inverted. We refer to cold clouds with spectra which are more than 2 K inverted as DCCi2. Associated with DCCi2 is a very high rain rate and a local upward displacement of the tropopause, a cold "bulge", which can be seen directly in the brightness temperatures of AIRS and Advanced Microwave Sounding Unit (AMSU) temperature sounding channels in the lower stratosphere. The very high rain rate and the local distortion of the tropopause indicate that DCCi2 objects are associated with severe storms. Significant long-term trends in the statistical properties of DCCi2 could be interesting indicators of climate change. While the analysis of the nature and physical conditions related to DCCi2 requires hyperspectral infrared and microwave data, the identification of DCCi2 requires only one good window channel and one strong CO<sub>2</sub> sounding channel. This suggests that improved identification of severe storms with future advanced geostationary satellites could be accomplished with the addition of one or two narrow band channels

    Comparing efficacy of montelukast versus doxycycline in treatment of moderate acne

    Get PDF
    Background: Treatment of acne is an important issue for reducing the cosmetic and psychological burden of disease. Regarding the inflammatory effect of LT-B4 in acne lesions and action mechanism of Montelukast, this study was performed to determine the efficacy of Montelukastin acne treatment comparison with doxycycline. Materials and Methods: In a randomized clinical trial that was performed in Dermatology Clinic in a Training Tertiary Health Care Center in Tehran, Iran since January 2012 to May 2014, 52 patients with moderate acne were evaluated. The included patients were randomly assigned to receive doxycycline 100 mg/day plus 1 Clindamycin solution (Group 1) or Montelukast 5 mg daily plus 1 clindamycin solution (Group 2). The acne severity index was measured and compared between two groups at baseline (on admission), 1-month and 3 months later. Independent-Sample-T, Chi-Square, and Repeated-Measure ANOVA tests were used and were considered statistically significant at P < 0.05. Results: The mean age was 26.8 ± 7.1 in Group 1 and25 ± 4.8 in Group 2 (P = 0.1). 73 women and 26.7 4 men in Group 1 and 86.7 women, and 13.3 men in Group 2 (P = 0.01). The mean acne severity index at baseline was 18.2 ± 6.1 and 19 ± 4.2 in Montelukast and doxycycline group, respectively (P = 0.679). The mean acne severity index after 1-month was 10.5 ± 6.2 and 12.9 ± 3.3 in Montelukast and doxycycline group, respectively (P = 0). Finally, the mean acne severity index after 3 months follow-up was 8.6 ± 4.8 and 8.2 ± 1.2 in Montelukast and doxycycline group, respectively (P = 0.01). There was no significant difference between two groups regarding the amount of decrease in acne severity index across the study (P = 0.186). However, each groups showed a significant reduction in the acne severity index, separately (P = 0.001). Conclusion: It may be concluded that Montelukast is an effective and safe medication for moderate-level acne treatment. © 2015, Isfahan University of Medical Sciences(IUMS). All rights reserved
    corecore